Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

NCT05999240 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]
DRUG: Placebo

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]